• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER NEG BREAKPOINT COMBO 47; MICRO DILUTION PANEL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER NEG BREAKPOINT COMBO 47; MICRO DILUTION PANEL Back to Search Results
Model Number N/A
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Patient Involvement (2645)
Event Date 02/12/2015
Event Type  malfunction  
Event Description
It was reported that upon initial test of the (b)(6) an identification of leminerolla sp 93.14% was obtained.Upon notification from (b)(6) of the incorrect result, 4-panels were set up, obtaining an identification of leminorella sp.93.14% on two panels, and shigella sp.99.30% on the other two panels.The customer indicated that biochemical and minimum inhibitory concentration (mic) panel qc were within specification before and after the reported misidentification.The correct identification of the isolate was shigella boydii per 2015 (b)(6) bacteriology participant summary report.There was no patient involved as this was a proficiency survey.
 
Manufacturer Narrative
The manufacturer participated in the same proficiency survey using (b)(6).When tested on conventional overnight panels and read on the wa instrument, an id of leminorella sp.93.14% was attained.When the same panel was read on the autoscan-4 (as-4) instrument, an id of shigella sp.99.30% was attained.The difference between the two reads was the cf8 (cephalothin 8 (ug/ml) well; the cf8 well was negative on the wa and positive on the as-4.It was noted that the cf8 well was a weak positive when visually verified.The results from the cf8 panel along with the panel results from the other biochemicals/antimicrobics are used to generate the biotype number for the organism tested and the corresponding identification.An id of shigella was also attained on two additional tests using rapid negative panels.Also, the sample was tested on an analytical profile index (api) strip as a reference test method and a low probability id of shigella sp.Was attained.It is possible that emerging resistance with this organism may be contributing to the identification discrepancy.Please refer to medwatch report number 2919016-2015-00045 for report of a similar event.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEG BREAKPOINT COMBO 47
Type of Device
MICRO DILUTION PANEL
Manufacturer (Section D)
BECKMAN COULTER
2040 enterprise blvd
west sacramento CA 95691
Manufacturer (Section G)
BECKMAN COULTER
2040 enterprise blvd
west sacramento CA 95691
Manufacturer Contact
norma rahill
1584 enterprise blvd
west sacramento, CA 95691
9163742189
MDR Report Key4775092
MDR Text Key16184706
Report Number2919016-2015-00044
Device Sequence Number1
Product Code LRG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/15/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other Health Care Professional
Device Model NumberN/A
Device Catalogue NumberB1017-417
Device Lot NumberNOT PROVIDED
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/15/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-